We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
GXO Logistics
GXO
$5.5B
| $370K | ﹤0.01% |
7,592
-500
| -6% | -$19.9K |
|
1402
International Flavors & Fragrances
IFF
$22.2B
| $366K | ﹤0.01% |
4,980
-405
| -8% | -$30.6K |
|
|
ALE
1403
DELISTED
Allete
ALE
| $364K | ﹤0.01% |
5,687
-2,216
| -28% | -$144K |
|
1404
Amer Sports
AS
$17.8B
| $360K | ﹤0.01% |
9,295
+8,675
| +1,399% | +$267K |
|
|
TXNM
1405
TXNM Energy Inc
TXNM
$5.93B
| $356K | ﹤0.01% |
6,314
+199
| +3% | +$10.8K |
|
1406
Hasbro
HAS
$13.3B
| $355K | ﹤0.01% |
4,810
-1,730
| -26% | -$109K |
|
1407
Coda Octopus Group
CODA
$118M
| $354K | ﹤0.01% |
43,314
| – | – |
|
1408
Exponent
EXPO
$3.38B
| $354K | ﹤0.01% |
4,738
-69
| -1% | -$5.35K |
|
1409
Dollar General
DG
$27.8B
| $354K | ﹤0.01% |
3,093
+911
| +42% | +$90.4K |
|
1410
OSI Systems
OSIS
$3.36B
| $353K | ﹤0.01% |
1,572
-680
| -30% | -$145K |
|
1411
ADT
ADT
$5.45B
| $350K | ﹤0.01% |
41,307
+12,329
| +43% | +$101K |
|
1412
Regency Centers
REG
$13.8B
| $348K | ﹤0.01% |
4,887
-3,234
| -40% | -$231K |
|
1413
Acco Brands
ACCO
$396M
| $348K | ﹤0.01% |
97,222
-12,908
| -12% | -$47.7K |
|
1414
Warner Bros
WBD
$72.4B
| $345K | ﹤0.01% |
30,062
-10,252
| -25% | -$95.6K |
|
1415
Viper Energy
VNOM
$16B
| $343K | ﹤0.01% |
9,001
-542
| -6% | -$21.9K |
|
1416
Perrigo
PRGO
$1.99B
| $343K | ﹤0.01% |
12,834
-85
| -0.7% | -$2.23K |
|
|
NSA
1417
DELISTED
National Storage Affiliates Trust
NSA
| $339K | ﹤0.01% |
10,594
-1,992
| -16% | -$69.5K |
|
1418
KB Home
KBH
$3.35B
| $339K | ﹤0.01% |
6,396
-2,747
| -30% | -$146K |
|
1419
Federated Hermes
FHI
$4.84B
| $336K | ﹤0.01% |
7,592
| – | – |
|
1420
Corteva
CTVA
$55B
| $336K | ﹤0.01% |
4,506
+1,493
| +50% | +$99.5K |
|
1421
Newell Brands
NWL
$2.5B
| $333K | ﹤0.01% |
61,707
| – | – |
|
1422
Mercantile Bank Corp
MBWM
$1.03B
| $333K | ﹤0.01% |
7,178
+309
| +4% | +$13.4K |
|
1423
International Bancshares
IBOC
$4.39B
| $332K | ﹤0.01% |
4,989
-76
| -2% | -$4.74K |
|
|
RAL
1424
Ralliant Corp
RAL
$7.01B
| $326K | ﹤0.01% |
+6,725
| New | +$331K |
|
1425
Enliven Therapeutics
ELVN
$4.43B
| $323K | ﹤0.01% |
16,098
-52,953
| -77% | -$1M |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.